Exact Mass: 279.137
Exact Mass Matches: 279.137
Found 50 metabolites which its exact mass value is equals to given mass value 279.137
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
N-(1-Deoxy-1-fructosyl)valine
Fructose aminoacids are naturally occurring compounds derived from D-fructose and L-aminoacids. They are amadori products resulting from sugar-aminoacid interactions in food products, especially cooked foods [CCD] N-(1-Deoxy-1-fructosyl)valine is classified as a Natural Food Constituent (code WA) in the DFC.
2-Methyl-4'-(methylthio)-2-morpholinopropiophenone
Contragestazol
D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents
N-[(2R,3R,4S,6R)-4,6-Dihydroxy-6-methyl-2-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-3-yl]acetamide
Choline ascorbate
Choline ascorbate is also known as choline ascorbic acid. Choline ascorbate is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Choline ascorbate can be found in wild celery, which makes choline ascorbate a potential biomarker for the consumption of this food product.
2-Ethyl-3-methyl-10-methoxy-3H-1,3a,6-triazapyrene
2-Methyl-4-(Methylthio)-2-Morpholinopropiophenone
CONFIDENCE standard compound; INTERNAL_ID 1386; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7341; ORIGINAL_PRECURSOR_SCAN_NO 7339 CONFIDENCE standard compound; INTERNAL_ID 1386; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7389; ORIGINAL_PRECURSOR_SCAN_NO 7385 CONFIDENCE standard compound; INTERNAL_ID 1386; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7391; ORIGINAL_PRECURSOR_SCAN_NO 7389 CONFIDENCE standard compound; INTERNAL_ID 1386; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7426; ORIGINAL_PRECURSOR_SCAN_NO 7424 CONFIDENCE standard compound; INTERNAL_ID 1386; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7423; ORIGINAL_PRECURSOR_SCAN_NO 7421 CONFIDENCE standard compound; INTERNAL_ID 1386; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7431; ORIGINAL_PRECURSOR_SCAN_NO 7430
2-(4-methoxy-2-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
2-((tert-Butyldimethylsilyloxy)methyl)furo[3,2-b]pyridin-6-ol
N-[2-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide
ethyl 2-(4-fluorophenyl)-2-(4-oxopiperidin-1-yl)acetate
3-(5-amino-2-methylphenyl)-1,7-dimethyl-1,6-naphthyridin-2(1H)-one
tert-butyl N-[(3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]carbamate
N-(5-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide
N-(4-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide
Ramosetron
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents
1,1,2,2,2-pentafluoroethanolate,trimethyl-(N,N,N-trimethylcarbamimidoyl)azanium
2-(3-methoxy-4-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
5-[(1-Methylindole-3-yl)carbonyl]-4,5,6,7-tetrahydro-1H-bezimidazole
(R)-tert-Butyl 2-(methylcarbamoyl)piperazine-1-carboxylate hydrochloride
3-(4-FLUOROPHENYL)-5-ISOPROPYL-2-PHENYL-1H-PYRROLE
Tert-Butyl [(2-Amino-4-Oxo-4,7-Dihydro-3h-Pyrrolo[2,3-D]pyrimidin-5-Yl)methyl]carbamate
1H-3-Benzazepine, 6-chloro-2,3,4,5-tetrahydro-3-methyl-9-((3-methyl-2-butenyl)oxy)-
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
1-Azepanyl-[2-methoxy-4-(methylthio)phenyl]methanone
6-methyl-N-[(E)-[(E)-2-methyl-3-phenylprop-2-enylidene]amino]pyridine-3-carboxamide
4,6-dideoxy-4-(3-deoxy-L-glycero-tetronamido)-2-O-methyl-alpha-D-mannopyranose
APX-115 (free base)
APX-115 free base (Ewha-18278 free base) is a potent, orally active pan NADPH oxidase (Nox) inhibitor with Ki values of 1.08 μM, 0.57 μM, and 0.63 μM for Nox1, Nox2 and Nox4, respectively. APX-115 free base effectively prevents kidney injury[1].